Senseonics (SENS) Stock Price, News & Analysis

Company Overview

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts.

The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.

Founded in 1996 and based in Germantown, Maryland, Senseonics has pursued regulatory approvals and commercialization in the United States and other markets. Ascensia Diabetes Care has partnered with the company on the commercialization of Eversense products in multiple geographies.

Key Stats

• Today's Range: $9.76 to $10.15
• 50-Day Range: $7.40 to $10.42
• 52-Week Range: $4.79 to $13.98
• Volume: 59,301 shs
• Average Volume: 689,533 shs
• Market Capitalization: $407.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $14.40
• Consensus Rating: Hold

Senseonics Stock Analysis - MarketRank™

Senseonics scored higher than 73% of companies evaluated by MarketBeat, and ranked 176th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Senseonics has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

Senseonics has a consensus price target of $14.40, representing about 43.4% upside from its current price of $10.04.

Amount of Analyst Coverage

Senseonics has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Senseonics are expected to grow in the coming year, from ($2.30) to ($1.92) per share.

Price to Book Value per Share Ratio

Senseonics has a P/B Ratio of 5.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

11.90% of the float of Senseonics has been sold short.

Short Interest Ratio / Days to Cover

Senseonics has a short interest ratio ("days to cover") of 7.8.

Change versus previous month

Short interest in Senseonics has recently decreased by 2.71%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Senseonics does not currently pay a dividend.

Dividend Growth

Senseonics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.36

News Sentiment

Senseonics has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 42 news articles for Senseonics this week, compared to 3 articles on an average week.

Search Interest

Only 2 people have searched for SENS on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

MarketBeat Follows

2 people have added Senseonics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.2 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $125,298.00 in company stock, which represents 0.0299% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Senseonics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $125,298.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

4.70% of the stock of Senseonics is held by insiders.

Percentage Held by Institutions

12.36% of the stock of Senseonics is held by institutions.

Company Calendar

• Last Earnings: 11/09/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:SENS
• Previous Symbol: NYSE:SENS
• CIK: 1616543
• Web: senseonics.com
• Phone: (301) 515-7260
• Fax: 301-515-0988
• Employees: 130
• Year Founded: 1996

Price Target and Rating

• Average Price Target for Senseonics: $14.40
• High Price Target: $20.00
• Low Price Target: $10.00
• Potential Upside/Downside: +46.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$69.11 million
• Net Margins: -204.01%
• Pretax Margin: -204.04%
• Return on Equity: -186.11%
• Return on Assets: -86.21%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 5.92
• Quick Ratio: 6.40

Sales & Book Value

• Annual Sales: $35.26 million
• Price / Sales: 11.69
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.86 per share
• Price / Book: 5.30

Miscellaneous

• Outstanding Shares: 41,800,000
• Free Float: 39,838,000
• Market Cap: $412.27 million
• Optionable: Optionable
• Beta: 1.04